Skip to content

The efficacy of mindfulness on worry

Evaluation of the efficacy of mindfulness-based stress reduction on reduction on pathological worry in Non-clinical population

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016090329648N1
Enrollment
20
Registered
2016-11-26
Start date
2012-09-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Pathological worry. Condition 2: Pathological worry. Condition 3: Pathological worry. Psychological and behavioural factors associated with disorders or diseases classified elsewhere Adjustment disorders Neurasthenia

Interventions

Intervention 1: The control group in the study do not recieve intervention (no action). Intervention 2: The experimental group recieved 8 sessions of mindfulness-based stress reduction model (in two m
Behavior
The control group in the study do not recieve intervention (no action).
The experimental group recieved 8 sessions of mindfulness-based stress reduction model (in two mounts, each week one session, 2-2.5 hours).

Sponsors

Shahed University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 24 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:Engagement with education in undergraduate, gender of female, Being in the age range of 18to 24,Obtain a score of above Cut-off point in PSWQ (Cut-off point: 50),Do not receive drug or psychological treatment and or consulting in last year, Lack of generalized anxiety disorder or other psychological disorder. Exclusion criteria: Absence of the above conditions.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pathological worry. Timepoint: Pre - post test, folllow up. Method of measurement: Penn State Worry Questionnaire (PSWQ), GAD-7.;Meta worry. Timepoint: Pre- post worry, follow up. Method of measurement: Wells Anxiety Thoughts Inventory.

Secondary

MeasureTime frame
Positive and negative affect. Timepoint: Pre - post test, folllow up. Method of measurement: Positive and Negative Affect scale (PANAS).;Symptoms of depression. Timepoint: Pre - post test, folllow up. Method of measurement: Beck Depression Inventory (II).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Mohammadreza Shairi

Shahed University

Shairigm@yahoo.com+98 21 5121 2470

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026